🔒 Resistant Hypertension: When Blood Pressure Won’t Come Down

You’re taking three or four blood pressure medications, yet your readings remain stubbornly above 130/80 mmHg. This situation — called resistant hypertension — is both frustrating and risky. It indicates an underlying factor that hasn’t been addressed. Dr. Ravi Sishir Reddy explains what resistant hypertension really means, the hidden causes that keep blood pressure elevated, and the step‑by‑step approach to regaining control.

1. What Is Resistant Hypertension?

Resistant hypertension is defined as blood pressure that remains above target (usually ≥130/80 mmHg) despite adherence to three or more antihypertensive medications of different classes at optimal doses, including a diuretic (unless contraindicated). It does not include patients who have not yet tried adequate therapy or who are not taking their medications properly.

True resistant hypertension affects about 10–20% of treated hypertensive patients. Pseudo‑resistance — due to poor adherence, incorrect measurement technique, or white coat effect — is even more common and must be ruled out first.

2. Rule Out Pseudo‑Resistance First

Before diagnosing true resistant hypertension, Dr. Reddy emphasises checking for these common confounders:

• Improper blood pressure measurement: Using a cuff that’s too small, measuring over clothing, or not resting beforehand can produce falsely high readings.
• White coat effect: High in clinic but normal at home. Confirm with home monitoring or 24‑hour ABPM.
• Medication non‑adherence: Missing doses, even occasionally, is one of the most common reasons for apparent resistant hypertension. A frank, non‑judgemental discussion with the patient is essential.
• Suboptimal drug regimen: Doses that are too low, missing a diuretic, or using drugs that interact (e.g., NSAIDs) can undermine control.

3. Causes of True Resistant Hypertension

Once pseudo‑resistance is excluded, a systematic search for secondary causes is required. Common underlying factors include:

• Obstructive sleep apnea (OSA): Present in up to 70% of patients with resistant hypertension. Repeated nighttime oxygen drops drive sympathetic overactivity, raising BP throughout the day.
• Primary aldosteronism (Conn’s syndrome): Excess aldosterone causes sodium retention and potassium loss. It’s estimated to be the cause in about 20% of resistant hypertension cases.
• Renal artery stenosis: Narrowing of the arteries supplying the kidneys, often due to atherosclerosis, triggers renin release and severe hypertension.
• Chronic kidney disease: Impaired sodium excretion and fluid overload.
• Obesity: Excess adipose tissue promotes inflammation, insulin resistance, and sympathetic activation.
• Medications and substances: NSAIDs, oral contraceptives, decongestants, corticosteroids, excessive alcohol, and illicit stimulants can all elevate BP.
• Rare endocrine causes: Pheochromocytoma, Cushing’s syndrome, thyroid disease.

4. Diagnostic Workup for Resistant Hypertension

Patients with confirmed resistant hypertension should undergo:

• Ambulatory blood pressure monitoring (ABPM) to confirm true resistance vs. white coat effect.
• Blood tests: Renal function (eGFR), electrolytes (especially potassium), aldosterone‑to‑renin ratio (ARR) for primary aldosteronism, thyroid function, and glucose/HbA1c.
• Urine tests: Urine albumin‑creatinine ratio, and in suspected pheochromocytoma, metanephrines.
• Imaging: Renal artery Doppler ultrasound (or CT/MR angiography) to screen for renal artery stenosis.
• Echocardiogram: To assess for left ventricular hypertrophy, a marker of long‑standing pressure load.
• Sleep study (polysomnography): If OSA is clinically suspected (snoring, excessive daytime sleepiness).

5. How to Treat Resistant Hypertension

Management of true resistant hypertension is systematic and often involves multiple steps:

• Optimise the drug regimen: Ensure the patient is on three drugs at maximum tolerated doses, including a long‑acting thiazide‑type diuretic (e.g., chlorthalidone). Consider adding a mineralocorticoid receptor antagonist (spironolactone or eplerenone), which is particularly effective in resistant hypertension, especially when undiagnosed primary aldosteronism is present.
• Add a fourth or fifth drug: Options include beta‑blockers, alpha‑blockers, or centrally acting agents (clonidine, moxonidine). The choice is guided by comorbidities and tolerance.
• Treat the underlying cause: CPAP therapy for OSA, renal artery stenting in selected cases of renal artery stenosis, surgical removal of aldosterone‑producing adenomas, or medication adjustment if substance‑induced.
• Intensive lifestyle modification: Very low sodium diet (<1,500 mg/day), weight loss, regular exercise, and strict alcohol limitation.
• Renal denervation: A catheter‑based procedure that interrupts the sympathetic nerves in the renal arteries. It is reserved for patients with true resistant hypertension who do not respond to optimal medical therapy and have been carefully selected. It can reduce office and ambulatory BP by 5–10 mmHg on average.
• Close follow‑up: Resistant hypertension requires regular monitoring, often every few weeks initially, until control is achieved.

Dr. Reddy emphasises that most cases of apparent resistant hypertension can be improved dramatically once adherence, measurement technique, and secondary causes are systematically addressed.